Your new post is loading...
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases.
Via Krishan Maggon
|
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review and Collection |
Scoop.it!
Via Krishan Maggon
Leukemia accepted article preview 27 February 2015; doi: 10.1038/leu.2015.52
CD33 Specific Chimeric Antigen Receptor T Cells Exhibit Potent Preclinical Activity against Human Acute Myeloid LeukemiaS S Kenderian1,2,5, M Ruella1,5, O Shestova1, M Klichinsky1, V Aikawa3, J J D Morrissette3, J Scholler1, D Song1, D L Porter1,4, M Carroll4, C H June1 and S Gill1,4
1Translational Research Program, Abramson Family Research Cancer Institute, University of Pennsylvania, Philadelphia, PA2Division of Hematology and Bone Marrow Transplantation, Department of Internal Medicine, Mayo Clinic, Rochester, MN3Department of Pathology, University of Pennsylvania, Philadelphia, PA4Department of Hematology-Oncology, University of Pennsylvania, Philadelphia, PACorrespondence: S Gill, Translational Research Program, Smilow Translational Research Center, 8-196, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: saar.gill@uphs.upenn.edu
5These authors contributed equally to this study.
Received 30 October 2014; Accepted 19 February 2015
Accepted article preview online 27 February 2015